INDOLENT NON-HODGKIN LYMPHOMA
Clinical trials for INDOLENT NON-HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new INDOLENT NON-HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for INDOLENT NON-HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to control lymphoma, possibly stop treatment after remission
Disease control Recruiting nowThis study is testing a two-drug combination (acalabrutinib and obinutuzumab) for people with untreated, slow-growing non-Hodgkin lymphomas. The goal is to see if this approach can effectively control the cancer, improve quality of life, and determine if patients who achieve a co…
Matched conditions: INDOLENT NON-HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New 'Living Drug' trial targets advanced blood cancers
Disease control Recruiting nowThis early-stage trial is testing a new type of cell therapy for adults with certain blood cancers that have returned or not responded to standard treatments. Doctors modify a patient's own immune cells (T cells) in a lab to better recognize and attack cancer cells, then infuse t…
Matched conditions: INDOLENT NON-HODGKIN LYMPHOMA
Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
First human test for promising new cancer pill
Disease control Recruiting nowThis is an early safety study for a new drug called TAK-243 in adults with advanced solid tumors or lymphoma. The main goal is to find the safest dose and understand the side effects. Researchers will give the drug to about 95 patients and closely monitor how their bodies handle …
Matched conditions: INDOLENT NON-HODGKIN LYMPHOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 16, 2026 15:23 UTC
-
Can a workout boost your Body's defenses against cancer?
Knowledge-focused Recruiting nowThis study aims to understand how exercise affects the immune systems of people with slow-growing blood cancers like chronic lymphocytic leukemia (CLL) and indolent non-Hodgkin lymphoma. Researchers will measure immune cell activity in about 70 participants before and after a sin…
Matched conditions: INDOLENT NON-HODGKIN LYMPHOMA
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC